PetVivo acquired a 2% equity stake in Digital Landia, a pioneer in agentic AI solutions for a Pet AI platform.
“In March 2025, the Company signed a strategic alliance agreement with Digital Landia Corp, a pioneer in Agentic AI solutions for a Pet AI platform. Under the agreement, PetVivo exchanged $ 150,000 in 230,770 shares of restricted common stock for an approximate 2 % equity stake in Digital Landia, thereby becoming the Platinum Sponsor of the Pet AI community. PetVivo will also receive economic benefits from 3 million Digital Landia tokens expected to be launched upon proper market conditions. As an exclusive advertiser for lameness and joint affliction medical device products, as well as regenerative therapeutic products, PetVivo’s products, our SPRYNG ® with OsteoCushion ® Technology, will be promoted to users when the AI detects joint related afflictions or other degenerative afflictions in pets. Further with the strategic alliance agreement, the Company issued 1,000,000 warrants to Digital Landia fair valued at $ 35,197 .”